Kala Pharmaceuticals Inc. (KALA)
NASDAQ: KALA
· Real-Time Price · USD
7.69
-0.38 (-4.71%)
At close: Aug 15, 2025, 11:54 AM
13F Institute Ownership
Total Institutes of 29 in Kala Pharmaceuticals reduced their positions with a decrease of 3 investors compared to the previous quarter. An additional 680.89K shares, as total invested capital declined by $284.83K with ownership percentage dropping from 73.70% to 65.25%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 18.94% | 1.2M | +0.00% | 6.89M | 0.08% | May 15, 2025 |
| Cormorant Asset Management, LP | 9.50% | 603.03K | +0.00% | 3.46M | 0.26% | May 15, 2025 |
| Sr One Capital Management, LP | 9.44% | 598.94K | +0.00% | 3.43M | 0.88% | May 13, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.